Random triples
| Subject | Object |
|---|---|
| gptkb:Priority_Review_designation | 6 months |
| gptkb:510(k)_clearance_in_US | typically 90 days |
| gptkb:510(k)_premarket_notification_for_medical_devices | typically 90 days |
| gptkb:New_Drug_Applications_(NDA) | typically 10 months standard review |
| gptkb:New_Drug_Applications_(NDA) | 6 months priority review |